CASR and familial hypocalciuric hypercalcemia: Inactivating mutations in the CaSR gene, especially within the first 350 amino acids of the extracellular domain, lead to hypercalcemic disorders such as forms of primary hyperparathyroidism and familial hypocalciuric hypercalcemia (FHH) [129].